Philippen, Angela <br/><br/>
SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL).  [electronic resource] 

 -  British journal of haematology  Sep 2010 
 - 633-6 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2010.08244.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Base Sequence<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--genetics<br/>Leukemia, Lymphocytic, Chronic, B-Cell--genetics<br/>Neoplasm Proteins--genetics<br/>Point Mutation<br/>Polymorphism, Single Nucleotide<br/>Protein-Tyrosine Kinases--genetics<br/>Syk Kinase